Dr. Mikyung Yu is an instructor in the Farokhzad Lab at Harvard Medical School (HMS) and Brigham and Women’s Hospital (BWH). She received her Ph.D. in Life Sciences from Gwangju Institute of Science and Technology (GIST) for her research work on nanomedicine and biomaterials in South Korea (2010). She then served as postdoctoral fellow in the School of Life Sciences, GIST (2010-2012) and in the Laboratory of Nanomedicine and Biomaterials at HMS (2013-2015). She currently leads several projects aimed at the development of novel nanomedicines and biomarkers for atherosclerotic vascular diseases.
Dr. Morteza Mahmoudi is an instructor in the Farokhzad Lab at Harvard Medical School (HMS) and Brigham and Women’s Hospital (BWH). He is also the director of the NanoBio Interaction Laboratory (www.biospion.com) at Tehran University of Medical Sciences. He received his Ph.D. working the development of ultra-safe superparamagnetic iron oxide nanoparticles for various biomedical applications at Sharif University of Technology in 2009. He then attended several universities (e.g., University College Dublin, École Polytechnique Fédérale de Lausanne, University of Illinois Urbana-Champaign, and Stanford School of Medicine) as a postdoc/visiting-scholar/visiting-professor. Dr. Mahmoudi’s diverse engineering and medical training uniquely prepared him to perform multi-disciplinary research at the convergence of physics, chemistry, materials, biology, and medicine, which he now applies to the development of “smart” nanobio-materials for cancer therapy with predictable/controllable protein corona structure.
Dr. Wei Tao is an instructor in the Farokhzad Lab at Harvard Medical School and Brigham and Women’s Hospital. He received his Doctoral degree in Biology (2015) from Tsinghua University. During his Ph.D. study, he also attended Harvard University as a visiting PhD student (2014). His current research interest is developing novel theranostic 2D nanomaterials and multi-stage polymeric nanomedicines for biomedical applications, as well as revealing their nano-bio interactions. He is also a Founding Editor of the Topic-“Application of Nanobiotechnology in Pharmacology” for Frontiers in Pharmacology, which is #1 most cited open-access journal in Pharmacology & Pharmacy.